On December 31, Hangzhou Kangji Weijing Medical Robot Co., Ltd. announced that it has completed a 100 million yuan B+ round of financing. This round of financing received exclusive investment from Guotai Junan Innovation Investment Co., Ltd., while the strategic shareholder Kangji Medical continued to invest further, and Cole Capital acted as the exclusive financial advisor for this transaction. The funds raised will mainly be used to accelerate the commercialization process of products and promote the development and clinical registration of next-generation products and functions.

On December 31, Hangzhou Kangji Weijing Medical Robot Co., Ltd. announced that it has completed a 100 million yuan B+ round of financing. This round of financing received exclusive investment from Guotai Junan Innovation Investment Co., Ltd., while the strategic shareholder Kangji Medical continued to invest further, and Cole Capital acted as the exclusive financial advisor for this transaction. The funds raised will mainly be used to accelerate the commercialization process of products and promote the development and clinical registration of next-generation products and functions.